BUHLMANN_Calprotectin_Tunnel_950x350 New fCAL turbo Publication - New BÜHLMANN fCAL® turbo publication Nilsen, T. et. al.  A novel turbidimetric immunoassay for fecal calprotectin optimized for routine chemistry analyzers. J Clin Lab Anal. 2016 Sep 15. PMID:27629827 The publication describes the technical performance of the turbidimetric assay on the cobas c501 and the Mindray BS-380. Highlights from this Publication: Short assay time of 10 min with
sh_microtiterplatte_h BÜHLMANN calprotectin assays appear in more than 50 clinical publications - More than 50 independent publications have proven the clinical performance and reliability of our fecal calprotectin assays in diagnosis and monitoring of IBD patients. The BÜHLMANN fCAL® ELISA can therefore be considered as the gold standard in fecal calprotectin testing. Check out our key literature list now
Infliximab 950x350 First Quantum Blue® Infliximab Poster presented at ECCO 2016 - At the ECCO IBD meeting 2016 in Amsterdam the first poster on the performance of the BÜHLMANN Quantum Blue® Infliximab rapid test was presented, including data on high correlations to the Sanquin and Leuven  infliximab ELISA tests. The reaction from attendees was enthusiastic, and the application for a high quality quantitative rapid tool to measure

 

 

 

DGKL 2016

Date: 28 – 30 September 2016

Place: Mannheim, Germany

Deutscher Kongress der Laboratoriumsmedizin 2016. Besuchen Sie unseren Stand 353.

Deutscher Allergiekongress 2016

Date: 29 September – 1 October 2016

Place: Berlin, Germany

11. Deutscher Allergiekongress. Besuchen Sie unseren Stand A5.

GETAID 2016

Date: 30 September – 1 October 2016

Place: Paris, France

Séminaire GETAID REMIND

UEG Week 2016

Date: 15 – 19 October 2016

Place: Vienna, Austria

23rd United European Gastroenterology Week. Visit us at booth #X2/31.